Our Company at a Glance
Our Presence in Riyadh
SMC Healthcare plays a vital role in serving the growing population of Riyadh. Our two established hospitals and extensive outpatient network ensure broad accessibility to high-quality patient-led care. With three new hospitals under development in key north and north-western zones in Riyadh, SMC will significantly expand its reach, doubling both bed and outpatient clinic capacity and strengthening its leadership in the Kingdom's largest healthcare market.
Hospital Network
Our Partners
At SMC, stakeholder engagement is embedded in our governance framework and our strategic priorities. We engage closely with patients, employees, regulators, investors, and community partners to ensure that their expectations shape the services we provide and the decisions we make. This collaborative approach strengthens trust, supports transparency and enhances our long-term sustainability.
Launch of New Brand Identity
To support SMC's ambitions for innovative, patient-centered care, SMC's new brand highlighted the future-focus of the Company.
First Urological Surgery Using ILY_ROBOT
A national medical breakthrough was achieved by successfully performing Saudi Arabia's first urological surgery using the advanced ILY_ROBOT, offering reduced risks and faster recovery times.
Debut on Saudi Exchange
SMC successfully completed its IPO and was listed on the main market of Tadawul.
SMC 4 — Khuzam District Financing
To finance the construction of its fourth hospital in Riyadh, SMC signed an Islamic Credit Facility Agreement with an SAR 800 million long-term facility and an SAR 300 million short-term working capital facility.
Expansion of Outpatient Clinics
A lease agreement was signed for a new outpatient clinic center — SMC Clinics, Al Malqa, in Riyadh.
One-off Dividend
The Board of Directors of SMC recommended the distribution of a one-off dividend payment for shareholders, subject to approval of the General Assembly.
Al Wadi Real Estate Fund
SMC announced its intention to establish the close-ended Shariah-compliant real estate investment fund to build, manage and operate a multi-use facility.
2025 in Numbers
Our 2025 performance demonstrates strong operational momentum supported by rising patient demand, expanded clinical services and increased digital engagement. The following indicators summarize our operational and financial activity for the year, highlighting growth across key service lines and strategic priorities.
*(All Numbers In millions) SAR
*All financial metrics for FY2025 Includes a SAR 60.6 million one-off gain on sale of land contribution to the Wadi Fund project. Excluding this non-recurring item, underlying operating performance continued to reflect solid growth driven by improved service mix, operational efficiency and disciplined cost management.
*Numbers presented may not add up precisely to the totals provided due to rounding
Our Investment Case
SMC is a full-service healthcare provider, offering a broad range of specialized medical services that encompass the entire healthcare value chain. With our key specialties and advanced procedures, we are uniquely positioned to meet the diverse needs of patients, establishing a competitive edge within Saudi Arabia's private healthcare market.
SMC operates in a rapidly expanding healthcare market supported by strong macroeconomic fundamentals and demographic growth. Vision 2030 continues to prioritize healthcare transformation, with more than USD 1.3 trillion committed to mega and giga projects that enhance national infrastructure and unlock private-sector participation.
Saudi Arabia's GDP is projected to grow at a 3.7% CAGR between 2023 and 2035, with the population expected to reach 42.8 million. Healthcare demand is forecast to rise at a 4.6% CAGR, driven by higher chronic disease prevalence, broader insurance coverage and the shift toward private providers. These dynamics create a highly attractive environment for SMC's long-term expansion.
Riyadh remains one of the region's fastest-growing cities, with population expected to rise from 7.3 million in 2023 to 9.4 million by 2035. The northern corridor, in particular, is experiencing rapid development but remains underserved from a healthcare capacity perspective.
SMC is expanding strategically in Northern Riyadh, where three new hospitals under development will more than double our inpatient capacity to approximately 1,279 beds by 2029. With this footprint, SMC is positioned to become the leading private healthcare provider in the northern zone and one of the most accessible care networks in the capital.
SMC delivers a complete suite of specialized medical services across the full continuum of care, from general medicine and surgery to advanced specialties including neurology, endocrinology, gastroenterology, orthopedics, urology and ophthalmology.
We are recognized for leadership in complex procedures, including operating the first licensed corneal transplant center in the Saudi private sector and pioneering kidney transplant programs, with plans to introduce liver transplantation. This breadth of expertise reinforces our differentiated position and ensures high-quality, comprehensive care for a growing patient base.
SMC's 502 physicians, 1,077 nurses and 443 ancillary personnel form a highly skilled workforce delivering exceptional clinical outcomes, including a 0.08% surgical site infection rate and a 99.6% cardiac catheterization success rate.
Our digital-first approach further enhances the patient journey. In-house platforms and early AI adoption have modernized diagnostics, workflows and patient access. Today, 64.6% of appointments are booked via the mobile app, which also supports online check-ins and digital payments. These capabilities streamline care delivery, elevate the patient experience and strengthen SMC's position as an innovation-led provider.
SMC has demonstrated strong and consistent financial performance. Net Revenue by 7% to SAR 1,538.5 million, driven by sustained growth in patient volumes, expanded service offerings, and improved operational throughput across our facilities. Gross profit reached SAR 382.9 million, with a gross margin of 24.9%, reflecting disciplined cost management and operating leverage.
EBITDA increased by 25.0% YoY to SAR 416.5 million, with margin expanding to 27.1% from 23.2% in 2024, including a SAR 60.6 million one-off gain related to the sale of land from the Al Wadi Real Estate Fund. Net profit increased by 43.7% YoY to SAR 266.2 million, including the impact of the one-off transaction, highlighting the strength of our underlying operations and our ability to convert revenue growth into sustainable earnings.
SMC's growth strategy is supported by a robust expansion pipeline. Three new hospitals: SMC 3 – Northern Ring Road, SMC 4 – Khuzam Suburb, SMC 5 – Al Malqa District, SMC Outpatient Clinics – Al Malqa – are scheduled to open between 2026 and 2029, with financing already secured.
These facilities will add approximately 698 beds and 440 clinics across strategic locations in Riyadh. The development program is supported by a prudent capital structure that balances debt and internally generated cash flows. Complementary projects, such as the Wadi Fund hotel adjacent to SMC 3 – Northern Ring Road, will enhance the patient and visitor experience and support long-term value creation.
SMC is led by an experienced management team with more than 50 years of collective healthcare expertise. The CEO brings over 30 years of sector experience, while the CFO adds 35 years of financial and management leadership.
Additionally, SMC is overseen by a highly qualified Board of Directors that ensures adherence to strong governance practices and provides rigorous oversight. This leadership foundation supports disciplined strategic execution and reinforces SMC's long-term growth ambitions.